Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Leeksma, AC"'
Autor:
Leeksma AC; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Lymphoma and myeloma center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), The Netherlands., Derks IAM; Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Lymphoma and myeloma center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), The Netherlands., Garrick B; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA., Jongejan A; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Colombo M; Bristol Myers Squibb's Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Bloedjes T; Department of Pathology, Amsterdam University Medical Centers, Lymphoma and Myeloma Center Amsterdam (LYMMCARE), University of Amsterdam, The Netherlands., Trowe T; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA., Leisten JC; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Howarth M; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA., Malek M; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA., Mortensen DS; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Blease K; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Groza MC; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Narla RK; Discovery, Bristol Myers Squibb, San Diego, CA, USA., Loos R; Bristol Myers Squibb's Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Moerland PD; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Guikema JEJ; Department of Pathology, Amsterdam University Medical Centers, Lymphoma and Myeloma Center Amsterdam (LYMMCARE), University of Amsterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Lymphoma and myeloma center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), The Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.; Lymphoma and myeloma center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), The Netherlands., Filvaroff EH; Translational Research, Bristol Myers Squibb, San Francisco, CA, USA.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Feb; Vol. 17 (2), pp. 284-297. Date of Electronic Publication: 2022 Dec 16.
Autor:
Baliakas, P, Jeromin, S, Iskas, M, Puiggros, A, Plevova, K, Nguyen-Khac, F, Davis, Z, Rigolin, GM, Visentin, A, Xochelli, A, Delgado, J, Baran-Marszak, F, Stalika, E, Abrisqueta, P, Durechova, K, Papaioannou, G, Eclache, V, Dimou, M, Iliakis, T, Collado, R, Doubek, M, Calasanz, MJ, Ruiz-Xiville, N, Moreno, C, Jarosova, M, Leeksma, AC, Panayiotidis, P, Podgornik, H, Cymbalista, F, Anagnostopoulos, A, Trentin, L, Stavroyianni, N, Davi, F, Ghia, P, Kater, AP, Cuneo, A, Pospisilova, S, Espinet, B, Athanasiadou, A, Oscier, D, Haferlach, C, Stamatopoulos, K, ERIC European Res Initiative CLL
Publikováno v:
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Recent evidence suggests that complex karyotype (CK) defined by the presence of >= 3 chromosomal aberrations (structural and/or numerical) identified by using chromosome-banding analysis (CBA) may be relevant for treatment decision-making in chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9f9f689ecd14b481ee08ad2c93add567
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2924
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2924
Autor:
Leeksma AC; Department of Hematology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), Amsterdam, Netherlands., Derks IAM; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), Amsterdam, Netherlands., Kasem MH; Translational Functional Cancer Genomics, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Kilic E; Department of Ophthalmology and Clinical Genetics Erasmus MC, Rotterdam, Netherlands., de Klein A; Department of Ophthalmology and Clinical Genetics Erasmus MC, Rotterdam, Netherlands., Jager MJ; Department of Ophthalmology, LUMC, Leiden, Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Centers, Location VUMC, Amsterdam, Netherlands., Jansen JH; Laboratory of Hematology, Department Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands., Navrkalova V; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Center of Molecular Medicine, CEITEC, Masaryk University, Brno, Czechia., Faber LM; Department of Internal Medicine, Rode Kruis Ziekenhuis, Beverwijk, Netherlands., Zaborsky N; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.; Department of Internal Medicine III with Haematology, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria.; Department of Internal Medicine III with Haematology, Cancer Cluster Salzburg, Salzburg, Austria., Egle A; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.; Department of Internal Medicine III with Haematology, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria.; Department of Internal Medicine III with Haematology, Cancer Cluster Salzburg, Salzburg, Austria., Zenz T; Department of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland., Pospisilova S; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Center of Molecular Medicine, CEITEC, Masaryk University, Brno, Czechia., Abdel-Wahab O; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Kater AP; Department of Hematology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Cancer Center Amsterdam (CCA) and Amsterdam Infection and Immunity Institute (AIII), Amsterdam, Netherlands.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Jan 29; Vol. 10, pp. 609409. Date of Electronic Publication: 2021 Jan 29 (Print Publication: 2020).
Autor:
Leeksma AC; Amsterdam University Medical Centers, University of Amsterdam., Baliakas P; Dept of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden., Moysiadis T; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Puiggros A; Hospital del Mar, Barcelona., Plevova K; University Hospital Brno, Masaryk University, Brno, Czech Republic., Van der Kevie-Kersemaekers AM; Dept of Clinical Genetics, Amsterdam University Medical Centers, Univ of Amsterdam, The Netherlands., Posthuma H; Dept of Clinical Genetics, Amsterdam University Medical Centers, Univ of Amsterdam, The Netherlands., Rodriguez-Vicente AE; IBSAL, IBMCC, Centro de Investigación del Cancer, Universidad de Salamanca-CSIC, Spain., Tran AN; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Barbany G; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Mansouri L; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Gunnarsson R; Division of Clinical Genetics, Dept of Laboratory Medicine, Lund University, Lund, Sweden., Parker H; Cancer Genomics, Academic Unit of Cancer Sciences, University of Southampton, Southampton, UK., Van den Berg E; Dept of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands., Bellido M; Dept of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands., Davis Z; Dept of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Wall M; Cytogenetics department, St Vincent Hospital Melbourne, Victoria, Australia., Scarpelli I; Oncogenomic laboratory, Dept of Hematology, Lausanne University Hospital (CHUV), Switzerland., Österborg A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Hansson L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm., Jarosova M; University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Ghia P; Dept. of Experimental Oncology, IRCCS Ospedale San Raffaele, Università Vita-Salute, Milan., Poddighe P; Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, The Netherlands., Espinet B; Laboratori de Citogenetica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain., Pospisilova S; CEITEC, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Tam C; St Vincent Hospital Melbourne, Peter MacCallum Cancer Center, University of Melbourne, Australia., Ysebaert L; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Nguyen-Khac F; Service d'Hematologie Biologique, Hopital Pitié-Salpetriere, APHP, Paris, France., Oscier D; Dept of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Schoumans J; Oncogenomic laboratory, Dept of Hematology, Lausanne University Hospital (CHUV), Switzerland., Stevens-Kroef M; Radboud University Medical Center, Dept of Human Genetics, Nijmegen, The Netherlands., Eldering E; Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Rosenquist R; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Strefford JC; Cancer Genomics, Academic Unit of Cancer Sciences, University of Southampton., Mellink C; Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Kater AP; Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands.
Publikováno v:
Haematologica [Haematologica] 2021 Jan 01; Vol. 106 (1), pp. 87-97. Date of Electronic Publication: 2021 Jan 01.
Autor:
Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Jeromin S; MLL Munich Leukemia Laboratory, Munich, Germany., Iskas M; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Puiggros A; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.; Grup de Recerca Translacional en Neoplàsies Hematològiques, Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Plevova K; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Nguyen-Khac F; Hematology Department and Sorbonne University, Hopital Pitie-Salpetriere, INSERM U1138, Paris, France., Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Rigolin GM; Hematology Section, St. Anna University Hospital, Ferrara, Italy., Visentin A; Hematology Division, Department of Medicine, University of Padua, Padua, Italy., Xochelli A; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Delgado J; Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain., Baran-Marszak F; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Stalika E; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Abrisqueta P; Servei d'Hematología, Hospital Vall d'Hebron, Barcelona, Spain., Durechova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Papaioannou G; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Eclache V; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Dimou M; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Iliakis T; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Collado R; Servicio de Hematología, Consorcio Hospital General Universitario, Valencia, Spain., Doubek M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Calasanz MJ; Servicio de Genética Citogenética, Departamento de Genética, Universidad de Navarra, Pamplona, Spain., Ruiz-Xiville N; Servei Laboratori Hematologia, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Moreno C; Servei d'Hematologia, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain., Jarosova M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Leeksma AC; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Panayiotidis P; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Podgornik H; Department of Hematology, University Medical Centre Ljubljana, Ljubljana, Slovenia; and., Cymbalista F; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Anagnostopoulos A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Trentin L; Hematology Division, Department of Medicine, University of Padua, Padua, Italy., Stavroyianni N; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Davi F; Hematology Department and Sorbonne University, Hopital Pitie-Salpetriere, INSERM U1138, Paris, France., Ghia P; Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy., Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Cuneo A; Hematology Section, St. Anna University Hospital, Ferrara, Italy., Pospisilova S; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Espinet B; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.; Grup de Recerca Translacional en Neoplàsies Hematològiques, Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Athanasiadou A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Stamatopoulos K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
Publikováno v:
Blood [Blood] 2019 Mar 14; Vol. 133 (11), pp. 1205-1216. Date of Electronic Publication: 2019 Jan 02.
Autor:
Leeksma AC; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Taylor J; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu B; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Gardner JR; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., He J; Foundation Medicine, Inc., Cambridge, MA, USA., Nahas M; Foundation Medicine, Inc., Cambridge, MA, USA., Gonen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alemayehu WG; HOVON Data Center, Erasmus MC, Daniel Den Hoedkliniek, Rotterdam, The Netherlands., Te Raa D; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Walther T; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hüllein J; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Dietrich S; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany., Claus R; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Haematology/Oncology, Augsburg Hospital, Augsburg, Germany., de Boer F; Department of Internal medicine, Ikazia Hospital, Rotterdam, The Netherlands., de Heer K; Department of Internal medicine, Flevo Hospital, Almere, The Netherlands., Dubois J; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Dampmann M; Department of Haematology, University Hospital Essen, Essen, Germany., Dürig J; Department of Haematology, University Hospital Essen, Essen, Germany., van Oers MHJ; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Eldering E; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Levine RL; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Miller V; Foundation Medicine, Inc., Cambridge, MA, USA., Mughal T; Foundation Medicine, Inc., Cambridge, MA, USA., Lamanna N; Department of Medicine, Columbia University Medical Center, New York, USA., Frattini MG; Department of Medicine, Columbia University Medical Center, New York, USA., Heaney ML; Department of Medicine, Columbia University Medical Center, New York, USA., Zelenetz A; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zenz T; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Haematology, University Hospital Zürich and University of Zürich, Zürich, Switzerland., Abdel-Wahab O; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. abdelwao@mskcc.org., Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands. a.p.kater@amc.uva.nl.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands. a.p.kater@amc.uva.nl.
Publikováno v:
Leukemia [Leukemia] 2019 Feb; Vol. 33 (2), pp. 390-402. Date of Electronic Publication: 2018 Jul 23.
Autor:
te Raa GD; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Moerland PD; Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands., Leeksma AC; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Derks IA; Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Yigittop H; MRC-Holland, Amsterdam, The Netherlands., Laddach N; MRC-Holland, Amsterdam, The Netherlands., Loden-van Straaten M; MRC-Holland, Amsterdam, The Netherlands., Navrkalova V; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Trbusek M; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Luijks DM; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Zenz T; Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Skowronska A; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Stankovic T; School of Cancer Sciences, University of Birmingham, Birmingham, UK., van Oers MH; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands., Eldering E; 1] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [2] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands., Kater AP; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [3] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands.
Publikováno v:
Cell death & disease [Cell Death Dis] 2015 Aug 06; Vol. 6, pp. e1852. Date of Electronic Publication: 2015 Aug 06.
Autor:
Stamatopoulos, Kostas, Pavlova, Sarka, Al‐Sawaf, Othman, Chatzikonstantinou, Thomas, Karamanidou, Christina, Gaidano, Gianluca, Cymbalista, Florence, Kater, Arnon P., Rawstron, Andy, Scarfò, Lydia, Ghia, Paolo, Rosenquist, Richard
Publikováno v:
HemaSphere; Jul2024, Vol. 8 Issue 7, p1-12, 12p
Publikováno v:
EJHaem; Feb2024, Vol. 5 Issue 1, p247-250, 4p
Autor:
Kontandreopoulou, Christina-Nefeli1 (AUTHOR), Diamantopoulos, Panagiotis T.1 (AUTHOR), Giannopoulos, Andreas2 (AUTHOR), Symeonidis, Argiris3 (AUTHOR), Kotsianidis, Ioannis4 (AUTHOR), Pappa, Vasiliki5 (AUTHOR), Galanopoulos, Athanasios6 (AUTHOR), Panayiotidis, Panayiotis7 (AUTHOR), Dimou, Maria7 (AUTHOR), Solomou, Elena3 (AUTHOR), Loupis, Theodoros2 (AUTHOR), Zoi, Katerina2 (AUTHOR), Giannakopoulou, Nefeli1 (AUTHOR), Dryllis, Georgios1 (AUTHOR), Hatzidavid, Sevastianos1 (AUTHOR), Viniou, Nora-Athina1 (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Mar2022, Vol. 63 Issue 3, p729-737. 9p.